Synapse - Eric Smith

Search Within

Eric Smith

Results (76)

Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis

Journal Article

Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials

Meeting Abstract

Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Capture rate of V(D)J sequencing for minimal residual disease detection in multiple myeloma

Journal Article

Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Jacob, A.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Smith, E. L.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection

Journal Article

Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
Molecular Therapy (2021)

Fulltext@MSK | Save

Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients

Meeting Abstract

Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing

Journal Article

Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
Molecular Therapy - Methods & Clinical Development (2021)

Fulltext@MSK | Save

Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone

Research Letter

Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
American Journal of Hematology (2021)

Fulltext@MSK | Save

Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy

Journal Article

Eveillard, M.; Korde, N.; Ciardiello, A.; Diamond, B.; Lesokhin, A.; Mailankody, S.; Smith, E.; Hassoun, H.; Hultcrantz, M.; Shah, U.; more...
Clinica Chimica Acta (2021)

Fulltext@MSK | Save

Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma

Journal Article

de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
Blood Cancer Discovery (2020)

Fulltext@MSK | Save

COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: A cohort study from five academic centers

Journal Article

Hultcrantz, M.; Richter, J.; Rosenbaum, C. A.; Patel, D.; Smith, E. L.; Korde, N.; Lu, S. X.; Mailankody, S.; Shah, U. A.; Lesokhin, A. M.; more...
Blood Cancer Discovery (2020)

Fulltext@MSK | Save